BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17031762)

  • 1. [The rationale for imaging methods in head and neck oncology].
    Westhofen M
    Laryngorhinootologie; 2006 Oct; 85(10):720-2. PubMed ID: 17031762
    [No Abstract]   [Full Text] [Related]  

  • 2. PET in face and neck tumours.
    Rankin SC
    Cancer Imaging; 2006 Oct; 6(Spec No A):S89-95. PubMed ID: 17114083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of positron emission tomography-computed tomography image fusion in the diagnosis of head and neck cancer: does it really improve staging and management?
    de Casso C; Visvanathan V; Soni-Jaiswall A; Kane T; Nigam A
    J Laryngol Otol; 2012 Mar; 126(3):295-301. PubMed ID: 22251666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A head and neck surgeon's perspective on best practices for the use of PET/CT scans for the diagnosis and treatment of head and neck cancers.
    Funk GF
    Arch Otolaryngol Head Neck Surg; 2012 Aug; 138(8):748-52. PubMed ID: 22911297
    [No Abstract]   [Full Text] [Related]  

  • 5. A head and neck radiologist's perspective on best practices for the usage of PET/CT scans for the diagnosis and treatment of head and neck cancers.
    Zollinger LV; Wiggins RH
    Arch Otolaryngol Head Neck Surg; 2012 Aug; 138(8):754-8. PubMed ID: 22911298
    [No Abstract]   [Full Text] [Related]  

  • 6. Positron emission tomography in cancer of the head and neck.
    Hain SF
    Br J Oral Maxillofac Surg; 2005 Feb; 43(1):1-6. PubMed ID: 15620766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current status of positron-emission tomography scanning in the evaluation and follow-up of patients with head and neck cancer.
    Kutler DI; Wong RJ; Schoder H; Kraus DH
    Curr Opin Otolaryngol Head Neck Surg; 2006 Apr; 14(2):73-81. PubMed ID: 16552262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The integrated PET/CT: technological advance in diagnostics of head and neck recurrencies and CUP?].
    Schneider K; Aschoff P; Bihl H; Hagen R
    Laryngorhinootologie; 2006 Mar; 85(3):179-83. PubMed ID: 16547893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of PET/CT for diagnosis of head and neck cancer].
    Horiuchi C
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1235-9. PubMed ID: 20684088
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional imaging in head and neck cancer.
    Kutler DI; Wong RJ; Kraus DH
    Curr Oncol Rep; 2005 Mar; 7(2):137-44. PubMed ID: 15717948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of positron emission tomography scanning in occult and recurrent head and neck cancer.
    Manolidis S; Donald PJ; Volk P; Pounds TR
    Acta Otolaryngol Suppl; 1998; 534():1-11. PubMed ID: 9726577
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical impact of positron emission tomography (PET) with (18F)fluorodeoxyglucose (FDG) in head and neck tumours.
    Ekberg T; Sörensen J; Engström M; Blomquist E; Sundin A; Anniko M
    Acta Otolaryngol; 2007 Feb; 127(2):186-93. PubMed ID: 17364351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
    Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A
    Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracranial head and neck neoplasms: role of imaging.
    Petrou M; Mukherji SK
    Cancer Treat Res; 2008; 143():93-117. PubMed ID: 18619215
    [No Abstract]   [Full Text] [Related]  

  • 15. Positron emission tomography/computed tomography true fusion imaging in clinical head and neck oncology: early experience.
    Yau YY; Samman N; Yeung RW
    J Oral Maxillofac Surg; 2005 Apr; 63(4):479-86. PubMed ID: 15789319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing staging by positron emission tomography with contrast-enhanced computed tomography and by pathology in head and neck squamous cell carcinoma.
    Qualliotine JR; Mydlarz WK; Chan JY; Zhou X; Wang H; Agrawal N
    J Laryngol Otol; 2015 Dec; 129(12):1213-9. PubMed ID: 26490394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of primary carcinoma by positron emission tomography in an unknown primary tumor with cervical metastasis: a case report].
    Cakli H; Altin F; Ak I; Gürbüz MK; Ozüdoğru E
    Kulak Burun Bogaz Ihtis Derg; 2005; 14(1-2):39-43. PubMed ID: 16227723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG-PET staging of head and neck cancer--can improved imaging lead to improved treatment?
    Schwartz DL; Macapinlac HA; Weber RS
    J Natl Cancer Inst; 2008 May; 100(10):688-9. PubMed ID: 18477798
    [No Abstract]   [Full Text] [Related]  

  • 19. [Positron emission tomography in head and neck oncology: five cases].
    Courtois A; Foehrenbach H; Maszelin P; De Dreuille O; Garcia D; Kossowski M; Merlet P; Gaillard JF; Poncet JL
    Ann Otolaryngol Chir Cervicofac; 2001 Sep; 118(4):254-60. PubMed ID: 11679846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of FDG-PET for head and neck cancer.
    Wong RJ
    J Surg Oncol; 2008 Jun; 97(8):649-52. PubMed ID: 18493944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.